Significant Improvements of Machined Surface Qualities by Electrical Multi-channel Discharging in Precision Manufacturing
管理员回复
CPCI还未检索收录!
盛虎 发布于:2023-09-07 已回复
Can the Opening of China-European Railway Express Enhance Technical Sophistication of Export? A Quasi-Natural Experiment Evidence from 273 Cities in China
管理员回复
CPCI还未检索收录!
林 发布于:2023-09-06 已回复
文章标题: Limitations in the CAR-T therapy for diffuse large B-cell lymphoma 作者:Zhen Lin 数据库:CPCI 备注:Highlights in Science, Engineering and Technology Volume 36, Year 2023 请帮我查看是否有CPCI检索,谢谢。
管理员回复
你好,CPCI数据库还未检索收录!
张 发布于:2023-09-06 未回复
《Classification of Glass Products Based on Clustering Algorithm》
来源:2023 5th International Conference on Materials Science, Machinery and Energy Engineering
是否被收入
管理员回复
张先生 发布于:2023-09-02 未回复
Automatic Detection of Peeled Shrimp Based on Image Enhancement and Convolutional Neural Networks.
作者:Yu, Huihui, Liu, Xiong; Qin, Hanxiang有没有被CPCI检索。
管理员回复
彭女士 发布于:2023-09-02 未回复
标题:Research on the Investment Value of Stocks of the CITIC Securities Company
作者:Zhuyin Li , Wen Peng
数据库:Conference Proceedings Citation Index (CPCI),Google Scholar
请问这篇paper是否被收录
管理员回复
李 发布于:2023-09-01 未回复
题目:Comprehensive Utilization Model of Yarlung Zangbo River Water Resources Based on Discrete Multi-objective Optimization Model,数据库:CPCI,会议名称:2023 3rd International Conference on Environment
Science and Advanced Energy Technologies.(2023第3届环境科学与先进能源技术国际会议),劳烦您查一下这篇文章是否被收录。
管理员回复
傅女士 发布于:2023-08-30 未回复
标题:Application And Exploration of Virtual And Augmented Reality Technology in The Practical Teaching of Art Brokerage in Higher Vocational Colleges,作者: Bing Fu,数据库: CPCI 备注:2022 International Conference on Science Education and Art Appreciation
管理员回复
黄乐富 发布于:2023-08-30 未回复
2023EBMT大会摘要 S213 EFFICACY AND SAFETY OF HUMANIZED VERSUS MURINIZED CD19 AND CD22 CAR-T CELL COCKTAIL THERAPY FOR REFRACTORY/RELAPSED B-CELL LYMPHOMA是否被收入。
管理员回复
黄乐富 发布于:2023-08-30 未回复
2023年EHA大会摘要 P1170 CAR-T THERAPY IS EFFECTIVE AND SAFE IN TREATING RELAPSED/REFRACTORY LYMPHOMA WITH MALIGNANT SEROUS CAVITY EFFUSION是否被收入